Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
Blood|September 20, 2017
Ibrutinib for chronic graft-versus-host disease after failure of prior therapyDavid Miklos, Corey S Cutler, Mukta Arora, et al.American Journal of Hematology|February 16, 2019
Outcomes with ibrutinib by line of therapy and post-ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysisSusan M O'Brien, John C Byrd, Peter Hillmen, et al.Clinical Lymphoma, Myeloma & Leukemia|August 1, 2018
Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell LymphomaSusan O'Brien, Peter Hillmen, Steven Coutre, et al.Nature|November 19, 2020
A molecular cell atlas of the human lung from single-cell RNA sequencingKyle J Travaglini, Ahmad N Nabhan, Lolita Penland, et al.Blood Advances|June 15, 2019
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studiesSteven E Coutre, John C Byrd, Peter Hillmen, et al.Cell Reports|December 3, 2014
iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's diseaseChris M Woodard, Brian A Campos, Sheng-Han Kuo, et al.The Journal of Clinical Investigation|February 11, 2014
5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathyDanos C Christodoulou, Hiroko Wakimoto, Kenji Onoue, et al.British Journal of Cancer|December 21, 2019
Drug responses are conserved across patient-derived xenograft models of melanoma leading to identification of novel drug combination therapiesRyan J Ice, Michelle Chen, Max Sidorov, et al.British Journal of Haematology|December 4, 2018
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysisJennifer R Brown, Javid Moslehi, Michael S Ewer, et al.Journal of the National Cancer Institute|September 5, 2012
Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomasArthur P Chou, Reshmi Chowdhury, Sichen Li, et al.Pageof 6